The SU.VI.MAX trial on antioxidants.
Hercberg
S
S
U557 INSERM/U1125 INRA, ISTNA-CNAM, 5, rue Vertbois, 75003 Paris, France.
Galan
P
P
Preziosi
P
P
Malvy
M
M
Briançon
S
S
Ait
Hadad M
HM
Rahim
B
B
Favier
A
A
D000328:Adult; D000975:Antioxidants / Q000008:administration & dosage* / Q000627:therapeutic use; D002908:Chronic Disease; D015331:Cohort Studies; D019587:Dietary Supplements; D004311:Double-Blind Method; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D015994:Incidence; D008137:Longitudinal Studies; D008297:Male; D008875:Middle Aged; D008903:Minerals / Q000008:administration & dosage* / Q000627:therapeutic use; D017202:Myocardial Ischemia / Q000453:epidemiology / Q000401:mortality / Q000517:prevention & control*; D009369:Neoplasms / Q000453:epidemiology / Q000401:mortality / Q000517:prevention & control*; D009752:Nutritional Status; D011322:Primary Prevention; D016896:Treatment Outcome; D014815:Vitamins / Q000008:administration & dosage* / Q000627:therapeutic use
D000975:Antioxidants; D008903:Minerals; D014815:Vitamins